Manulife (Manufacturers Life Insurance)’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.46M | Buy |
154,980
+20,187
| +15% | +$581K | ﹤0.01% | 1216 |
|
|
2025
Q1 | $4.52M | Sell |
134,793
-14,163
| -10% | -$475K | ﹤0.01% | 1207 |
|
|
2024
Q4 | $7.62M | Buy |
148,956
+14,869
| +11% | +$760K | 0.01% | 1017 |
|
|
2024
Q3 | $6.85M | Buy |
134,087
+3,024
| +2% | +$155K | 0.01% | 1078 |
|
|
2024
Q2 | $5.87M | Buy |
131,063
+23,398
| +22% | +$1.05M | 0.01% | 1100 |
|
|
2024
Q1 | $5.04M | Buy |
107,665
+26,699
| +33% | +$1.25M | ﹤0.01% | 1190 |
|
|
2023
Q4 | $2.88M | Buy |
80,966
+17,083
| +27% | +$608K | ﹤0.01% | 1355 |
|
|
2023
Q3 | $1.9M | Buy |
63,883
+12,723
| +25% | +$378K | ﹤0.01% | 1453 |
|
|
2023
Q2 | $922K | Buy |
51,160
+30,745
| +151% | +$554K | ﹤0.01% | 1699 |
|
|
2023
Q1 | $328K | Hold |
20,415
| – | – | ﹤0.01% | 2251 |
|
|
2022
Q4 | $374K | Buy |
20,415
+22
| +0.1% | +$403 | ﹤0.01% | 2167 |
|
|
2022
Q3 | $401K | Sell |
20,393
-447
| -2% | -$8.78K | ﹤0.01% | 2123 |
|
|
2022
Q2 | $389K | Buy |
20,840
+2,880
| +16% | +$53.7K | ﹤0.01% | 2213 |
|
|
2022
Q1 | $394K | Sell |
17,960
-4,090
| -19% | -$89.8K | ﹤0.01% | 2337 |
|
|
2021
Q4 | $626 | Buy |
22,050
+1,849
| +9% | +$52 | ﹤0.01% | 2119 |
|
|
2021
Q3 | $425K | Sell |
20,201
-1,599
| -7% | -$33.6K | ﹤0.01% | 2414 |
|
|
2021
Q2 | $411K | Buy |
21,800
+4,481
| +26% | +$84.5K | ﹤0.01% | 2571 |
|
|
2021
Q1 | $265K | Buy |
17,319
+76
| +0.4% | +$1.16K | ﹤0.01% | 2696 |
|
|
2020
Q4 | $243K | Buy |
17,243
+830
| +5% | +$11.7K | ﹤0.01% | 2649 |
|
|
2020
Q3 | $257K | Hold |
16,413
| – | – | ﹤0.01% | 2402 |
|
|
2020
Q2 | $293K | Buy |
+16,413
| New | +$293K | ﹤0.01% | 2270 |
|